Metabolic dysfunction-associated steatotic liver disease (MASLD)


MASLD is a highly prevalent, multifactorial disease with significant implications for medication management. Pharmacist-led medication reviews are essential to improving clinical outcomes, reducing adverse events, and supporting integrated care. By Debbie Rigby, advanced practice pharmacist Learning outcomes After completing this activity, pharmacists should be able to: identify and interpret the disease spectrum of metabolic dysfunction-associated

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?